1

Drug Eluting Balloon Market is driven by rising CAD prevalence

News Discuss 
Drug Eluting Balloons (DEBs) are minimally invasive angioplasty devices that integrate drug delivery with mechanical dilation to treat coronary and peripheral arterial lesions. Coated with antiproliferative agents such as paclitaxel or sirolimus analogues, these balloons provide uniform drug distribution to the vascular wall, significantly reducing neointimal hyperplasia and restenosi... https://justpaste.it/f3cz12

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story